The European Patent Office Releases Innovation Cases Focusing on Intellectual Property Commercialization

Recently, the European Patent Office (EPO) released a series of innovation cases, revealing how innovators can better utilize the intellectual property system to create value. Most of these cases involve the intellectual property and technology transfer of small and medium-sized enterprises (SMEs), showcasing commercialization practices in Europe's major regions, industries, and innovation ecosystems, covering the application of various business models.

European SMEs, universities, professional research institutions, and independent inventors contribute to over one-quarter of the total patent applications received by the European Patent Office, serving as a core engine driving innovation, employment, and economic growth. The case studies compile the essence of successful innovators' experiences, covering key aspects such as how to develop proactive intellectual property strategies to support business growth, implement holistic intellectual property management strategies, integrate professional talent resources, and utilize patent information. Additionally, the cases reveal the challenges faced by startups during the process of commercialization or business model expansion. Key technology transfer cases include:

1. In the field of sustainable transportation, Lightyear (Netherlands), from solar-powered cars to technology licensing.

2. In the field of sustainable agriculture, Arevo (Sweden), how to attract investment and foster innovation through a robust intellectual property strategy.

3. In the field of biotechnology, OncoQR (Austria), enhancing immune response to combat cancer; OncoMark (Ireland), smarter early-stage breast cancer prognostic detection.

4. In the field of technical textiles, Oxeon (Sweden), textiles for extreme environments.

5. In the field of medical devices, Atlantic Therapeutics (Ireland), improving quality of life.

6. In the field of medical equipment, Dermis Pharma (Turkey), wound healing.

7. In the field of transportation, Blubrake (Italy), safe cycling for a better future.

8. In the field of additive manufacturing, Cubicure (Austria), reshaping the landscape of 3D printing.

9. In the field of medical imaging, Perceive3D (Portugal), revolutionizing surgical navigation.

10. In the field of measurement technology, fos4X (Germany), blade sensors.

These cases cover multiple countries, industry sectors, and types of technology transfer, revealing how innovators use the intellectual property system to create value and achieve market success. They provide key insights for stakeholders such as universities, public research institutions, and enterprises, highlighting the importance of patents for technology transfer in startups, spin-offs, and established companies.

Taking the Austrian biotechnology company OncoQR's case of "enhancing immune response to combat cancer" as an example, two scientists turned entrepreneurs developed an immunology vaccine platform technology (applicable for treating allergies and cancer). Relying on a strong patent portfolio, they founded OncoQR and several other startups dedicated to product development and technology commercialization. Intellectual property is crucial for attracting investment, while early-stage licensing revenue also provides financial support for the typically long development cycles common in the biotechnology field. Key insights include:

First, as long as key stakeholders fulfill their commitments and control the intellectual property, the termination of a research project or commercial project does not mean the end of the related technology and intellectual property.
Second, establishing licensing agreements that incorporate multiple payment methods can both ensure a "commercial portfolio" and maximize the value of the technology for stakeholders.
Third, incorporating mechanisms in licensing agreements to access technological improvements from other licensees is an effective way to continuously enhance the value of platform technologies and simplify negotiation processes in the long term.
Fourth, protecting platform technologies through a combination of "patents + trade secrets" can both strengthen infringement defenses and extend the protection period.